Unigestion Holding’s Pediatrix Medical MD Stock Holding History

Unigestion Holding’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-40,200	Closed	-$1.74M	–	335
2018 Q2	$1.74M	Buy	+40,200	New	+$1.93M	0.03%	229

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Unigestion Holding's MD Position: Q3 2018 in Review

Unigestion Holding sold out of Pediatrix Medical (MD) in Q3 2018, closing a stake of 40,200 shares — an estimated $1.74M sold.

Unigestion Holding first reported a position in MD in Q2 2018 and held it in 1 quarter. The position peaked at $1.74M in Q2 2018. 320 funds tracked by Wall St. Rank hold MD as of Q3 2018.

Unigestion Holding reported no remaining Pediatrix Medical position as of Q3 2018 after selling out during the quarter.
Unigestion Holding sold 40,200 Pediatrix Medical shares in Q3 2018, an estimated $1.74M.
Unigestion Holding first reported a position in Pediatrix Medical in Q2 2018 and held it in 1 quarter.
Unigestion Holding's Pediatrix Medical position peaked at $1.74M in Q2 2018.
320 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2018.

Based on Unigestion Holding's 13F filing for Q3 2018, filed 5 Nov 2018.